Novartis Pharma: The Business Unit Model

Below are the available bulk discount rates for each individual item when you purchase a certain amount

Register as a Premium Educator at hbsp.harvard.edu, plan a course, and save your students up to 50% with your academic discount.

Publication Date:
January 23, 2001

Industry:
Pharmaceuticals

Source:
Harvard Business School

In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing). The new organization created a matrix structure and new roles and responsibilities for heads of business functions, CEOs of new business units, and country managers operating in over 100 countries.

Copyright © 2021 Harvard Business School Publishing. All rights reserved. Harvard Business Publishing is an affiliate of Harvard Business School.

Novartis Pharma: The Business Unit Model

Research & References of Novartis Pharma: The Business Unit Model|A&C Accounting And Tax Services
Source

error: Content is protected !!